COMMUNIQUÉS West-GlobeNewswire

Spectral Announces Voting Results of Annual Meeting

07/06/2018 - 22:00

TORONTO, June 07, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) (OTCQX:EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a [...]

Trillium Dental Celebrates Grand Opening of Eighth Location in Ottawa

07/06/2018 - 21:00

OTTAWA, June 07, 2018 (GLOBE NEWSWIRE) -- Trillium Dental ®, recognized as Ottawa’s largest name in dentistry, celebrated the grand opening of its newest dental clinic located at 1110 Carp Road, in Stittsville with a [...]

Grant of Restricted Stock Units and Warrants to Genmab employees

07/06/2018 - 20:31

Company Announcement Copenhagen, Denmark; June 7, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 5,305 restricted stock units and 14,714 warrants to [...]

PACE Consultants Dorothy Ginsberg and Mandy Hurley Join Tabula Rasa HealthCare

07/06/2018 - 20:17

Capstone Performance System subsidiary to offer expanded PACE Technical Assistance Center ST. LOUIS and MOORESTOWN, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Capstone Performance Systems, a Tabula Rasa HealthCare (NASDAQ: [...]

Syapse Launches Precision Medicine Council to Advance Health System Adoption of Precision Oncology

07/06/2018 - 19:00

A group of the nation’s leading health systems will share best practices and strategies to accelerate precision medicine SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- Syapse, the leading precision medicine company, [...]

Photocure ASA: Mandatory notification of trade

07/06/2018 - 16:51

Jan H. Egberts, Chairperson of the Board of Photocure ASA and primary insider in Photocure ASA, has on 7 June 2018 purchased 12,500 shares in Photocure ASA at a price of NOK 27.6687 per share. Following the transaction [...]

Recording of the First Quarter 2018 Investor Conference Webinar

07/06/2018 - 16:18

Recording of the First Quarter 2018 Investor Conference Webinar On June 7 AS „Olainfarm” organized its Investor Conference Online Webinar. During the webinar the member of the management board of AS „Olainfarm” Salvis [...]

Navamedic ASA: Annual General Meeting held

07/06/2018 - 15:31

Navamedic ASA has today, 7 June 2018, held an annual general meeting. All resolutions were made in accordance with the board's/nomination committee's proposals. The minutes from the general meeting is attached hereto [...]

NYMOX Successfully Achieves Manufacturing Scale-Up

07/06/2018 - 15:30

HASBROUCK HEIGHTS, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report that manufacturing scale-up milestones have been reached for the Company's lead compound [...]

BIOMODEX Raises an Additional $15M in Series A Funding

07/06/2018 - 15:15

Latest investment from Idinvest Partners and InnovAllianz to support technological development and enable the opening a manufacturing facility in Massachusetts Boston, June 07, 2018 (GLOBE NEWSWIRE) -- BIOMODEX , a [...]

Maury Jayson, MD to Offer Minimally Invasive HIFU Treatment to Men with Localized Prostate Cancer in South Florida

07/06/2018 - 15:00

HIFU, or high intensity focused ultrasound, is a non-invasive, outpatient, radiation-free treatment for prostate cancer CHARLOTTE, N.C., June 07, 2018 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC (HPS), the leading [...]

MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension Advancing Development to Next Phase

07/06/2018 - 15:00

Study achieved primary endpoint of safety and tolerability Progressive dosing of Treprostinil Technosphere (TreT) significantly exceeded the corresponding peak plasma and exposure levels of the maximum recommended dose [...]

Olainfarm holds First Quarter 2018 Investor Conference Webinar

07/06/2018 - 15:00

Olainfarm holds First Quarter 2018 Investor Conference Webinar AS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on June [...]

CohBar Announces the Appointment of Dr. Philippe Calais to its Board

07/06/2018 - 14:59

MENLO PARK, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (“CohBar” or the “Company”), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related [...]

Radius Health to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

07/06/2018 - 14:30

WALTHAM, Mass., June 07, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that Jesper Høiland, President and Chief Executive Officer and Pepe Carmona, Senior Vice President and Chief Financial [...]

Sarepta Therapeutics Appoints Gilmore O’Neill, M.B., M.M.Sc. as Chief Medical Officer

07/06/2018 - 14:30

-- Dr. O’Neill joins Sarepta from Biogen, where he served as senior vice president of late-stage clinical development, including Spinraza® for spinal muscular atrophy (SMA); brings deep clinical experience in neurology [...]

K2M Surpasses 100th Product Milestone with FDA Clearance and Launch of OZARK™ Cervical Plate Systems

07/06/2018 - 14:30

Achievement highlights K2M’s broad impact on treating spinal disease LEESBURG, Va., June 07, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the “Company” or “K2M”), a global leader of complex spine and [...]

Onconova Therapeutics Announces Presentation at the 23rd Congress of the European Hematology Association

07/06/2018 - 14:30

NEWTOWN, Pa., June 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]

Cellectar Granted U.S. Patent for the Treatment of Various Cancers and Cancer Stem Cells with CLR 131

07/06/2018 - 14:30

MADISON, Wis., June 07, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments [...]